Pfizer
Search results
Bristol Myers Squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines to patients with serious diseases.
The Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb (BMS), is an American multinational pharmaceutical company. Headquartered in Princeton, New Jersey, BMS is one of the world's largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations. For fiscal 2022, it had a total revenue of $46.2 billion.
Bristol Myers Squibb India has been providing medication to patients in India for more than a decade. At Bristol Myers Squibb India, the work of our employees is focused on helping patients prevail over serious diseases. Our team is dedicated to researching, developing and delivering life-saving and life-enhancing innovative medicines. At the end of the day, our success as a leader in biopharmaceuticals is measured by the difference we make in the lives of the patients.
At Bristol Myers Squibb, we work every day to transform patients’ lives through science. We combine the agility of a biotech with the reach and resources of an established pharmaceutical company to create a global leading biopharma company powered by talented individuals who drive scientific innovation.
Bristol Myers Squibb | 1,434,392 followers on LinkedIn. At Bristol Myers Squibb, we work every day to transform patients’ lives through science. That work inspires some of the most interesting ...
At Bristol Myers Squibb, your work helps people prevail over serious diseases. From the scientists behind the microscope to the analysts behind the data, everyone at BMS is working to make an impact. And while our work transforms the lives of patients, it also transforms the lives and careers of our people.
Bristol-Myers Squibb is a leading worldwide biopharmaceutical company. Its products focus on oncology, immunology and cardiovascular conditions. The company completed its merger with Celgene in ...
Feb 2, 2023 · NEW YORK--(BUSINESS WIRE)-- Bristol Myers Squibb (NYSE:BMY) today reports results for the fourth quarter and full year of 2022, which reflect robust growth of the in-line and new product portfolios, driven by strong commercial execution and continued progress of the company's pipeline. “2022 was a successful year for our company, one of significant clinical and regulatory achievements that broadened our product portfolio and advanced our pipeline,” said Giovanni Caforio, M.D., board ...
While joining Bristol Myers Squibb during her treatment journey, she found strength and support in her colleagues. Click here to learn more about Atiba's journey. Our Mission To discover, develop and deliver innovative medicines that help patients prevail over serious diseases Our Vision To be the world’s leading biopharma company that transforms patients’ lives through science
1 day ago · Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where ...
